as on February 4, 2026 at 2:29 am IST
Day's Low
Day's High
-8.14%
Downside
16.28%
Upside
52 Week's Low
52 Week's High
62.12%
Downside
75.58%
Upside
Check Oncolytics Biotech Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$121.6M
EPS (TTM)
-0.363
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-34.9M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-769.06%
Compare market cap, revenue, PE, and other key metrics of Oncolytics Biotech Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $121.6M | -62.61% | NA | 0.00% | |
| BUY | $122.3B | 123.7% | 33.56 | 31.35% | |
| BUY | $47.7B | 124.2% | 1246.03 | 1.36% | |
| NA | $37.4B | NA | 662.33 | 1.38% | |
| BUY | $80.8B | 53.72% | 18.28 | 32.13% |
The Oncolytics Biotech Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Oncolytics Biotech Inc investment value today
Current value as on today
₹1,28,375
Returns
₹28,375
(+28.37%)
Returns from Oncolytics Biotech Inc Stock
₹24,638 (+24.64%)
Dollar Returns*
₹3,737 (+3.74%)
Based on 11 analysts
90.91%
Buy
9.09%
Hold
0.00%
Sell
Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Oncolytics Biotech Inc. Average target price of $5.6
Get share price movements and forecasts by analysts on Oncolytics Biotech Inc.
What analysts predicted
84.64%UPSIDE
Target Price
$5.6
Current Price
$0.86
Analyzed by
11 Analysts
Target
$5.60
Oncolytics Biotech Inc target price $5.6, a slight upside of 84.64% compared to current price of $0.86. According to 11 analysts rating.
Search interest for Oncolytics Biotech Inc Stock has increased by 58% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:58% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 16 September
Tue, 10:00 PM
-Oncolytics expands GOBLET study to U.S., showing promising early efficacy signals in gastrointestinal cancers.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
![]()
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 34.3% return, outperforming this stock by 80.8%
Against Peers
![]()
In the last 1 year, Beone Medicines Ltd has given 54.5% return, outperforming this stock by 15.1%
Price Dip
![]()
In the last 7 days, ONCY stock has moved down by -16.5%
| Organisation | Oncolytics Biotech Inc |
| Headquarters | 322 11th Avenue SW, Calgary, AB, Canada, T2R 0C5 |
| Industry | Health Technology |
| CEO | Mr. Jared Kelly J.D., L.L.M. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Thomas C. Heineman M.D., Ph.D. | Chief Medical Officer |
Ms. Allison Hagerman P.Eng., P.M.P. | Vice President of Product Development |
Jon Patton | Director of Investor Relations & Communication |
Yujun Wu | VP & Head of Biostatistics |
Mr. John Mark Lievonen B.B.A., CM, F.C.A., FCPA, LLD, M.B.A. | Consultant |
Mr. Kirk J. Look C.A., CPA | Chief Financial Officer |
Ms. Amy Goodowitz Levin B.S.N., R.N. | Vice President of Clinical Operations |
Mr. Jared Kelly J.D., L.L.M. | CEO & Director |
Mr. John McAdory | Executive VP of Strategy & Operations |
Mr. Andrew P. Aromando | Chief Business Officer |
Oncolytics Biotech Inc share price today is $0.86 as on at the close of the market. Oncolytics Biotech Inc share today touched a day high of $1 and a low of $0.93.
Oncolytics Biotech Inc share touched a 52 week high of $1.51 on and a 52 week low of $0.33 on . Oncolytics Biotech Inc stock price today i.e. is closed at $0.86,which is 43.05% down from its 52 week high and 163.97% up from its 52 week low.
Oncolytics Biotech Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Oncolytics Biotech Inc (ONCY) shares with as little as ₹90.22 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹902.20 in Oncolytics Biotech Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Oncolytics Biotech Inc share’s latest price of $0.86 as on February 4, 2026 at 2:29 am IST, you will get 11.6279 shares of Oncolytics Biotech Inc. Learn more about
fractional shares .
Oncolytics Biotech Inc stock has given -62.61% share price returns and 25.37% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?